Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy: Determining the Balance Between Benefits and Risks.

Trial Profile

Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy: Determining the Balance Between Benefits and Risks.

Completed
Phase of Trial: Phase III

Latest Information Update: 03 Dec 2016

At a glance

  • Drugs Dalteparin sodium (Primary) ; Nadroparin calcium (Primary)
  • Indications Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms Pot-Kast
  • Most Recent Events

    • 03 Dec 2016 Results of two trials (POT-KAST and POT-CAST) published in the New England Journal of Medicine
    • 10 Oct 2016 Status changed from active, no longer recruiting to completed.
    • 31 May 2016 Planned End Date changed from 1 May 2016 to 1 Jun 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top